JPRN-jRCT2080224981已完成2 期
Phase II Study of a Quadruple-modality Therapy: Induction Chemo-radiation Therapy Followed by Surgery with Perioperative Immunotherapy for Resectable Stage Discrete N2 III A-B Non-small Cell Lung Cancer (SQUAT trial)
Tetsuya Mitsudomi (Coordinating Investigator)0 个研究点目标入组 31 人开始时间: 2019年12月11日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •1.Patients with a histologically confirmed diagnosis of NSCLC
- •2.Clinical Stage T1-3N2 III A-B or T4N2 IIIB (solid diameter > 7cm)
- •3.Patients who were not previously treated for NSCLC
- •4. Patients who is possible to undergo complete resection
- •5. Patients to start radiation therapy based on the protocol in this study.
排除标准
- •1.Patients with active multiple primary cancer
- •2.Patients with autoimmune disorder including the history of treatment by immunosuppressive agent
- •3.Patients with interstitial lung disease on CT scan,
研究者
相似试验
已完成
2 期
A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung canceron-small cell lung cancerJPRN-UMIN000029435Department of respiratory medicine, Kurashiki Central Hospital20
进行中（未招募）
1 期
Trimodality therapy with or without adjuvant Durvalumab to treat patients with bladder cancerMuscle-invasive bladder cancerMedDRA version: 20.1 Level: PT Classification code 10066753 Term: Bladder transitional cell carcinoma stage II System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1 Level: PT Classification code 10066754 Term: Bladder transitional cell carcinoma stage III System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-001310-42-ESCanadian Cancer Trials Group (CCTG)238
进行中（未招募）
2 期
A Phase II trial looking at trimodality therapy with or without durvalumab for patients with muscle-invasive bladder cancerMuscle-invasive bladder cancerMalignant neoplasm of bladderCancerISRCTN65058008niversity Hospital Southampton NHS Foundation Trust82
进行中（未招募）
不适用
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
招募中
2 期
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumoron-metastatic Ewing Sarcoma Family TumorJPRN-UMIN000020903Japan Ewing Sarcoma Study Group66